Congenital Heart Futures Reauthorization Act of 2015 (HR 3952, 114th Congress)
What it does
Instructs numerous federal agencies to pursue activities to benefit congenital heart disease research and specifically allows for research into genetic causation.
Congressional Research Service - This bill amends the Public Health Service Act to replace the authorization for a National Congenital Heart Disease Surveillance System with a requirement for the Centers for Disease Control and Prevention (CDC), regarding congenital heart disease, to enhance and expand research and surveillance infrastructure, and plan and implement a public outreach and education campaign. (Congenital heart disease is a condition caused by a heart defect that is present at birth.)
The CDC must award grants to nonprofit entities to conduct: (1) a cohort study of congenital heart disease, from birth to adulthood, that considers health care utilization, demographic factors, and outcomes; and (2) an awareness, outreach, and education campaign regarding congenital heart disease.
The National Heart, Lung, and Blood Institute must report on its ongoing research efforts regarding congenital heart disease, future plans for such research, and areas of greatest need for such research.
Specifically, Section 3 of this legislation amends Section 425 of the Public Health Service Act (42 U.S.C. 285b–8) to read as follows:
“SEC. 425. CONGENITAL HEART DISEASE. “(a) In General.—The Director of the Institute may expand, intensify, and coordinate research and related activities of the Institute with respect to congenital heart disease, which may include congenital heart disease research with respect to— “(1) causation of congenital heart disease, including genetic causes;"